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ABSTRACT
The prevalence of metabolic syndrome (MetS) is high worldwide which it 
can increase the risk of some diseases such as cardiovascular disease, type 2 
diabetes mellitus even mortality. The prevalence pattern and determinants of 
MetS risk factors might differ among ethnics in Indonesia. This study aimed to 
determine the anthropometry and metabolic measurements determinants to 
predict the MetS prevalence of the Javanese population in Yogyakarta. It was 
a case control study conducted from December 2018 to March 2019 involving 
214 Javanese subjects aged 20-74 years resided in Yogyakarta Special Region, 
Indonesia. NCEP ATP III criteria were used to identify MetS as case and not 
diagnosed with MetS as control. The results showed that BMI, WC, BP, total 
cholesterol and HDL-C were significantly different between MetS and non 
MetS patients (p<0.005). In MetS subjects, prevalence of obesity was 75.3%, 
visceral fat was 75.3%, WC 92.95%, WHtR 97.64% and total cholesterol/HDL-C 
ratio 553%, which independently increased the risk of MetS 7.30, 5.32, 13.37, 
20.75, and 7.16 times, respectively. Result of logistic regression analysis showed 
central obesity based on WC increased the risk of Met-S by 17.62 time and the 
ratio of total cholesterol/HDL-C>5 by 9.54 time. In conclusion, WHtR is a better 
marker for MetS prediction independently. However, the WHtR in combination 
with WC and total cholesterol/HDL-C ratio are better for MetS prediction in the 
Javanese population. 
ABSTRAK
Prevalensi sindrom metabolic (SM) tinggi di seluruh dunia yang dapat 
meningkatkan risiko berbagai penyakit seperti kardiovaskular, diabetes 
melitus tipe 2 bahkan kematian. Pola prevalensi dan determinan faktor 
risiko SM mungkin berbeda antar etnik di Indonesia. Penelitian ini bertujuan 
untuk menetapkan determinan pengukuran antopometri danmetabolik 
untuk memprediksi SM pada etnis Jawa di Yogyakarta. Penelitian ini adalah 
penelitian kasus control yang dilakukan antra Desember 2018 sampai Maret 
2019 dengan melibatkan 214 orang Jawa berumur 20-74 tahun tinggal di 
Daerah Istimewa Yogyakarta, Indonesia. Kriteria NCEP ATP III digunakan 
untuk mengidentifikasi SM sebagai kelompok kasus dan tidak mengalami SM 
sebagai kelompok kontrol. Hasil penelitian menunjukkan bahwa BMI, WC, 
BP, kolesterol total dan HDL-C antara kelompok SM dan non SM (p<0,005). 
Pada kelompok SM, prevalensi obesitas adalah 75,3%, lemak visceral adalah 
75,3%, WC 92,95%, WHtR 97,64% dan rasio kolesterol total/HDL-C 55,3%, yang 
secara independen meningkatkan risiko SM masing-masing sebesar 7.30, 5.32, 
13.37, 20.75, dan 7.16 kali. Hasil analisis regresi logistik menunjukkan obesitas 
sentral berdasarkan WC meningkatkan risiko SM sebesar 17,62 kali dan rasio 
kolesterol total/HDL-C >5 sebesar 9,54 kali. Hasil penelitian menunjukkan 
bahwa WHtR adalah penanda yang lebih baik untuk memprediksi SM secara 
independent.Namun, WHtR bersama WC dan rasiokolesterol total/ HDL-C 
lebih baik untuk mengidentifikasi SM pada populasi Jawa.
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INTRODUCTION
Metabolic syndrome  (MetS) is  a 
major public health  problem worldwide. 
The data shows the prevalence of MetS 
ranges are <10% to 84% depending on 
the area in an urban or rural setting. The 
prevalences are the composition (gender, 
age, race, and ethnicity), the study of 
population, and the definition of the 
syndrome used.1 Metabolic syndrome has 
characterized with metabolic disorders 
such as hypertension, central obesity, 
insulin resistance, and atherogenic 
dyslipidemia. Itis strongly associated 
with an increased risk of developing 
atherosclerotic cardiovascular disease 
(CVD),2 type 2 diabetes mellitus (T2DM) 
and there is twice the risk of dying 
compared with those without the 
syndrome.1
Risk factors for MetS include 
psychosocial stress through 
disturbance of the balance of the 
homeostatic mechanism, specifically, 
the hypothalamic - pituitary - adrenal 
axis (HPA axis) hormone. Increased fat 
in the visceral area of central obesity 
sufferers will increase the risk of insulin 
resistance which is one of the criteria of 
MetS.3 Insulin resistance is a metabolic 
disorder characterized by an increase 
in insulin levels. This condition causes 
impaired glucose and fat metabolism, 
which increases the risk of mortality 
and morbidity due to MetS, T2DM and 
CVD.4 In Korea, low HDL-C cholesterol 
was the most prevalent determinant 
of MetS, followed by central obesity, 
hypertension, high triglyceride level and 
high fasting plasma glucose level.5
The  prevalence  of   MetS  in 
Yogyakarta is 13.19% based on 
International Diabetic Federation (IDF) 
with hypertension and dyslipidemia 
as the most common components.6 
The Ministry of Health of the Republic 
of Indonesia reported based on basic 
health research (Riset Kesehatan Dasar/
Riskesdas) data 2018 that prevalence 
of risk factors of non communicable 
diseases (NCD) in Yogyakarta including 
hypertension, poor lipid or cholesterol 
metabolism, high density lipoprotein-
cholesterol (HDL-C), low density 
lipoprotein - cholesterol (LDL-C), 
triglycerides for ages from 15 to 64 years, 
and T2DM were 32.68, 19.82, 24.62, 18.98, 
12.9, and 2.4%, respectively.7
The prevalence pattern of MetS risk 
factors might differ among ethnics in 
Indonesia due to different demographic 
and geographical factors. In addition, it 
may affect the impact of each component 
involved in MetS based on different MetS 
definitions.8 The aim of this study was 
to determine the anthropometry and 
metabolic measurements determinants 
to predict the MetS prevalence of the 
Javanese population in Yogyakarta 
Special Region, Indonesia based on 
National Cholesterol Education Program 
Adult Treatment Panel (NCEP ATP III).
MATERIALS AND METODES
Design and subject
It was a case-control study that 
aimed to examine various factors 
related with metabolic syndrome in 
Javanese subjects. This study was a part 
of the research entitled, “Polymorphism 
of nicotin amidephos phoribosyl 
transferase (NAMPT), fat mass and 
obesity-associated (FTO) and lipoprotein 
lipase (LPL) in metabolic syndrome 
sufferers in Yogyakarta, Indonesia”. 
A total of 214 participants selected on 
December 2018 until March 2019 from 
Yogyakarta region who met the inclusion 
and exclusion criteria ware involved in 
this study. The inclusion criteria were 
Javanese ethnicity aged 20-70 years 
who have at least three MetS criteria 
based on modified NCEP ATP III for the 
diagnosis of MetS.9 All participants in 
this study signed an informed consent 
form showing a willingness to involved 
in this study. The study was approved by 
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the Medical and Health Research Ethics 
Committee of the Faculty of Medicine, 
Public Health and Nursing, Universitas 
Gadjah Mada / Dr. Sardjito General 
Hospital, Yogyakarta with registration 
number KE/FK/0761/EC/2018.
Anthropometry, criteria of MetS and 
metabolic measurements
Anthropometry measurements 
included weight (kg), height (cm), visceral 
fat and waist circumference (WC) (cm). 
Measurement of body weight and visceral 
fat percentage using a digital scale by 
Karada-Scan (Karada Scan HBF 375, 
by Omron) and WC using a tape meter. 
Measurement of body weight, height and 
WC was performed on respondents using 
thin shirts, after removing sandals/shoes. 
Waist circumference was measured 
using a tape meter in horizontal at mid 
between boundary of kosta inferior and 
krista superior iliaka. Height and weight 
were used to body mass index (BMI). 
Measurements of blood pressure (BP) 
(mmHg) used a sphygmomanometer 
and were measured twice at the brachial 
artery and the intercostal fossa after 
resting for at least 3 min.
In the Asian sampling, the criteria 
for metabolic syndrome are based on 
the NCEP-ATP III modification. As for 
the Met-S criteria as a combination of 
three or more components based on 
the following components: increased 
waist circumference (WC), increased 
triglycerides (TG), reduced high-density 
lipoproteins - cholesterol (HDL-C-
Chol), increased blood pressure (BP), 
and increase fasting plasma glucose 
(FPG).10 Waist to height ratio (WHtR) was 
obtained based on the measurement 
of WC against height; central obesity 
based on WC > 80 cm in female and WC 
> 90 cm in male; and total cholesterol/
HDL-C ratio was obtained based on total 
cholesterol to HDL-C and categorized 
into two categories <5 and >5.
Metabolic measurements used 5 
mL peripheral blood collected in EDTA 
blood tubes after 8-10 h fasting. Total 
cholesterol and HDL-C were measured 
by enzymatic colorimetric techniques 
based on the manual auto-analyzer 
procedure using a Cob as c111 analyzer 
with protocol of HDL-C cholesterol Gen4 
and Cholesterol Gen2 (Roche Diagnostic 
R).
Statistical analysis
The basic characteristics of research 
subjects with continuing variables were 
tested for normality using Kolmogorov-
Smirnov. If the data were not normal 
then the transformation and normality 
tests were performed. Numerical 
variables are presented as mean mean± 
standard deviation (SD). Comparison of 
average age, HDL-C, FPG, BP and BMI 
used non-parametric tests; sex used Chi-
square test; WC and total cholesterol 
used independent t-test. The frequencies 
of anthropometry and metabolic 
measurements were compared by Chi-
square tests. Finally, if bivariate analysis 
results were significant, they were 
estimated by adjusted odds ratio (OR) 
with 95% CI from logistic regression 
analyses. The results of statistical 
analysis were considered significant if 
the p value <0.05.
RESULTS
Baseline characteristic
The total number of subjects in this 
study was 214 participants, with 85 
patients diagnosed with MetS and 129 
subjects non MetS as controls. Baseline 
characteristics between MetS and control 
subjects were significantly different in 
BMI, total cholesterol, HDL-C-Chol, WC, 
BP (p<0.05), but not significantly different 
between age, sex and FPG (TABLE 1).
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TABLE 1. Baseline characteristics of MetS and control subject
Characteristic MetS (n=85) Non-MetS (n=129) p
Aged (year) 45.31 (22.06-66.02) 44.91 (20.46-68.21) 0.988*
Sex (n)
0.681**•	 Female 47 75
•	 Male 38 54
Total cholesterol (mg/dL) 185.00 ± 39.25 161.34 ± 30.89 <0.001***
HDL-C-Chol (mg/dL) 184.10 (88.10-380.20) 161.50(74.90-250.20) <0.001*
FPG (mg/dL) 71.20(44.05-227.60) 72.00(41.90-224.90) 0.061*
Systolic BP (mmHg) 130.00(100.00-190.00) 115.00(90-175) <0.001*
Diastolic BP (mmHg) 85.00(60.00-145.00) 75.00(60.00-110.00) <0.001*
BMI (kg/m2) 29.20(18.8-42.2) 24.50(17.50-294.00) <0.001*
WC (cm) 96.24 ± 10.86 84.02 ± 9.63 <0.001***
*non-parametric test; **Chi-square test; ***independent t-test.
TABLE 2 shows that in the MetS 
group the prevalence of obesity with 
a BMI cut-off value>27 was 75.3% and 
the prevalence of the total cholesterol/
HDL-C ratio >5 was 55.3%. Obesity 
independently increased the risk of 
MetS by 7.30 times greater than non-
obesity and the ratio of cholesterol total/
HDL-C>5 independently increased the 
risk of MetS 7.16 times greater than the 
groups with a ratio of cholesterol total/
HDL-C<5. Based on the results of logistic 
regression analysis, obesity increased 
the risk of MetS by 6.93 and the ratio of 
total cholesterol/HDL-C>5 by 6.73.

















TABLE 3 shows that the prevalence 
of subjects with visceral fat>10% was 
75.3% and independently increased 
the risk of MetS by 5.32 times. Logistic 
regression analysis showed that visceral 
fat increased the risk of MetS by 5.65 and 
total cholesterol/HDL-C ratio of>5 by 4.12 
times.
TABLE 3. Odds ratio of visceral fat and metabolic measurement of MetS subjects
Anthropometry Prevalence p [Crude OR (95%CI)]
p
(Adjusted OR)
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TABLE 4 shows the prevalence 
of central obesity was 92.94 % and 
independently increased the risk of MetS 
by 13.37 times greater than non-central-
obesity. Based on the results of logistic 
regression analysis, central obesity 
increased the risk of MetS by 17.62 times 
along with the ratio of total cholesterol/
HDL-C>5 by 9.54. 
TABLE 5 reports the prevalence of 
WHtR was 97.64% and independently 
increased the risk of MetS by 20.75 times. 
Based on logistic regression analysis, 
WHtR increased the risk of MetS by 16.59 
times and the ratio of total cholesterol/
HDL-C >5 by 6.05 times.
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In this study, the prevalence and 
determinants of anthropometry and 
metabolic measurements of MetS 
according   NCEP   ATP  III  criteria 
in  subjects of Javanese ethnicity in 
Yogyakarta Special Region have been 
investigated. The obesity and central 
obesity  based on WC and WHtR 
increased the risk of MetS but WHtR 
more than WC.  This is different from 
the research conducted by Zhao et al.9 
in a Chinese population, that identified 
high blood pressure was the most 
common MetS component when using 
the modified ATP III criteria. There is 
a positive relationship between MetS 
and obesity parameters including BMI 
and the amount of fat under the skin 
(sum of skin-folds). It was reported 
that BMI, an index of general obesity, 
was positively correlated with systolic 
and diastolic blood pressure. That 
study showed that overweight subjects 
have increased risk of developing MetS 
5.54 times higher than patients with 
normal BMI. Obese people are at risk 
of developing MetS 7.44 times higher 
than normal patients. It was reported 
that obesity, both general and central, 
is a major determinant of hypertension 
in the general population.3 The higher 
BMI value does not always describe the 
high adipocyte mass value, because body 
weight does not differentiate between 
fat mass and tissue mass other than 
fat. Epidemiological studies also proved 
that the ability of BMI as a determinant 
to predict cardiometabolic risk is lower 
than WC and WHtR.4 Although BMI is 
being routinely measured at all ages 
because of its prognostic significance, it 
is not an accurate measure of adiposity. 
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BMI is in fact not able to differentiate fat- 
and fat-free tissues, and does not take into 
account body fat distribution, which may 
be more important than total adiposity 
as a risk factor for cardiometabolic 
disease.11
Logistic regression analysis showed 
a strong association between BMI and 
total cholesterol/HDL-C ratio with MetS. 
One study reported that patients with 
total cholesterol/HDL-C ratio >5 are at 
risk of developing MetS 8.8 times greater 
than those with ratio of total cholesterol/
HDL-C<5.3 Our study is consistent with 
that result and our research reports that 
subjects with total cholesterol/HDL-C 
ratio >5 are at risk of developing MetS 
7.16 times greater than those with the 
ratio of total cholesterol/HDL-C<5. The 
same was reported in Korean adolescents 
indicating that the distributions of 
thetriglyceride to HDL-C ratio and total 
cholesterol to HDL-C ratioare useful 
markers of MetS with high predictive 
value.12 Another research reported that 
the TG/HDL-C-C ratio is a better marker 
than the LDL-C/HDL-C ratio and the TC/
HDL-C ratio for identifying MetS in an 
Iranian population and could be used 
in clinical practice.13 The difference in 
results found may be due to differences 
in the criteria used in determining 
metabolic syndrome. Additionally, 
elevated TC / HDL-C may improve lipid 
profile to some extent through lifestyle 
changes, i.e. diet and physical activity.14
A recent meta-analysis in the 
Indonesian population reported that WC 
is the best anthropometric parameter for 
detecting MetS in adolescents because 
the value of area under curve (AUC) are 
higher than BMI and WHtR.15 Waist to 
height ratio is simple index to good proxy 
for central obesity and has substantial 
practical advantages. Therefore, WHtR 
represents a rapid and effective global 
indicator for health risks of obesity, and 
its use could simplify the international 
public health message.16
A similar results in Iran by 
Gharipour et al.17 indicated that WC is 
best obesity indicator for distinguishing 
MetS among Iranian elderly men. These 
results are different from our study, that 
found patients with high WHtR have a 
higher prevalence and increases risk of 
Mets by 20.75 times. Generally, WHtR 
values in Asian populations have better 
performance to describe cardiometabolic 
risk than WC, because WC cannot reflect 
the effect of height on cardiometabolic 
risk even though it represents abdominal 
fat mass. Likewise, the percentage of 
abdominal visceral fat is more associated 
with insulin resistance.17
Some research reported that WHtR 
is better than WC and BMI at predicting 
adiposity in children and adolescents. 
It can be a useful surrogate of body 
adiposity when the effect of age and 
gender is taken into account and when 
direct measures of subcutaneous fat (that 
is, skinfolds thickness) are not available,11 
Another study in a Chinese population 
reported that AUC cut-off values showed 
that the association of WHtR and WC 
was higher than that for BMI for all risk 
conditions for both sexes, except for 
hypertension in men. The AUC values 
for WC showed a higher association with 
hypertension and MetS for women than 
men. Compared with BMI, measures of 
central obesity, particularly WHtR, show 
a better association with obesity related 
cardiovascular diseases.18 Moreover, 
WHtR are not only effective as indicators 
of abdominal obesity, but also more 
effective parameters predicting risk 
factors for cardiovascular diseases. A 
study showed that WHtR is of great value 
for screening  populations at high risk for 
abdominal obesity and cardiovascular 
diseases and predicting the risk for 
cardiovascular diseases.19
Some limitations in this study are 
the small sample size and cross-sectional 
design. The study results need to be 
confirmed by long-term prospective 
studies with larger samples.
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CONCLUSION
In conclusion, WHtR is a better 
marker of risk factor for MetS 
independently. However in combination 
with WC and total cholesterol/HDL-C 
ratio, they are better for identifying MetS 
in the Javanese population.
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